
MDxHealth SA Hits New 52-Week High of $4.75, Up 313.72%
2025-10-02 22:32:56MDxHealth SA achieved a new 52-week high of USD 4.75 on October 1, 2025, reflecting a 313.72% increase over the past year. The company, with a market cap of USD 176 million, has shown impressive financial metrics despite being loss-making and not offering dividends.
Read More
MDxHealth SA Hits New 52-Week High of USD 4.74, Up 298%
2025-09-24 13:25:09MDxHealth SA achieved a new 52-week high of USD 4.74 on September 23, 2025, marking a 298.23% increase over the past year. With a market capitalization of USD 176 million, the company has a notable return on equity of 3,461.10%, despite not offering dividends and facing a complex valuation.
Read More
MDxHealth SA Hits New 52-Week High of $4.68, Up 314%
2025-09-23 15:36:15MDxHealth SA achieved a new 52-week high of USD 4.68 on September 22, 2025, reflecting a 314.16% increase over the past year. Despite being a loss-making microcap in the Pharmaceuticals & Biotechnology sector, the company boasts a market capitalization of USD 176 million and notable financial metrics.
Read More
MDxHealth SA Hits New 52-Week High of USD 4.17, Up 266% Year-Over-Year
2025-09-22 18:12:14MDxHealth SA achieved a new 52-week high of USD 4.17 on September 19, 2025, reflecting a substantial increase over the past year. The company, with a market capitalization of USD 176 million, has shown impressive financial metrics despite being currently loss-making, highlighting its volatility and growth potential in the pharmaceuticals sector.
Read MoreIs MDxHealth SA technically bullish or bearish?
2025-09-20 20:29:38As of 11 September 2025, the technical trend for MDxHealth SA has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands are bullish on both weekly and monthly time frames. Daily moving averages also indicate a bullish stance. However, the weekly RSI is bearish, and the KST shows a bullish weekly signal but a bearish monthly signal. Dow Theory reflects a mildly bullish outlook on both weekly and monthly time frames. In terms of performance, MDxHealth has significantly outperformed the S&P 500 across various periods, with a year-to-date return of 64.56% compared to the S&P 500's 12.22%, and a one-year return of 51.75% versus 17.14%. Overall, the current technical stance is bullish, supported by strong weekly indicators despite some mixed signals in the monthly data....
Read More
MDxHealth SA Hits New 52-Week High of USD 3.93, Up 245%
2025-09-19 13:01:12MDxHealth SA achieved a new 52-week high of USD 3.93 on September 18, 2025, reflecting a 245.13% increase over the past year. The company, with a market capitalization of USD 176 million, demonstrates strong operational efficiency despite being loss-making and lacking a dividend.
Read More





